InnoCan Pharma Corporation
INNPD
$12.53
-$0.39-3.02%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.37% | -410.53% | 60.69% | -186.05% | 119.07% |
| Total Depreciation and Amortization | -10.00% | 66.67% | -33.33% | -10.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.59% | 306.53% | -201.83% | 3,253.85% | -99.08% |
| Change in Net Operating Assets | 2,521.74% | -52.08% | 104.15% | -467.62% | 177.21% |
| Cash from Operations | 86.41% | 173.02% | 49.75% | -248.59% | 190.36% |
| Capital Expenditure | 80.00% | -25.00% | 33.33% | -100.00% | -50.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.00% | -98.55% | -- | -- | -- |
| Cash from Investing | 50.00% | -106.15% | 1,183.33% | -100.00% | -50.00% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 33.33% | 0.00% | -20.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -82.22% | -31.95% | 12.55% | -- | -100.00% |
| Cash from Financing | -84.64% | 149.00% | -53.43% | 17,280.00% | -100.34% |
| Foreign Exchange rate Adjustments | 1,866.67% | 70.00% | -155.56% | 124.66% | -911.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.41% | 2,869.39% | 62.88% | -122.22% | -16.34% |